Tranilast Market Projected to Reach USD 228 Million by 2032 at 6% CAGR

02/11/2026 4 Min. Lesezeit

Aufrufe

Market Overview

According to 24ChemicalResearch, the global Tranilast Market was valued at USD 143 million in 2024 and is projected to grow from USD 152 million in 2025 to USD 228 million by 2032, registering a compound annual growth rate (CAGR) of 6% during the forecast period.

Tranilast is an anti-allergic and anti-inflammatory pharmaceutical agent that inhibits the release of histamine and prostaglandins. It is used in applications related to conditions such as asthma, keloids, and hypertrophic scars, and also serves as a chemical intermediate in the synthesis of pharmaceutical compounds. The market includes products with different purity grades to meet pharmaceutical, industrial, and research requirements.

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/292491/global-tranilast-market
View Full Report: https://www.24chemicalresearch.com/reports/292491/global-tranilast-market

Market Dynamics

Key Market Drivers

Demand for Treatments for Allergic and Fibrotic Disorders: Tranilast's anti-allergic and anti-inflammatory properties support its use in applications involving allergic conditions and fibrotic disorders. Its established role in treating keloids and hypertrophic scars also contributes to demand.

Expanding Pharmaceutical Research: Research into potential applications beyond traditional uses is creating opportunities for Tranilast. Its anti-fibrotic and anti-proliferative mechanisms are being investigated for applications involving restenosis following coronary angioplasty and certain cancer-related research. These potential uses remain investigational, and further clinical evidence and regulatory approval would be needed for expanded indications.

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/292491/global-tranilast-market

Market Challenges and Restraints

The market faces pressure from generic competition following the loss of patent protection, which can contribute to price erosion and lower profit margins. Limited awareness and niche positioning may also restrict prescription volumes in some markets. Potential side effects, including liver-function abnormalities, and the need for multiple daily doses can affect patient compliance and prescribing decisions.

Regulatory requirements are another restraint on market expansion. New therapeutic indications require evidence from clinical trials to establish safety and efficacy. The cost and duration of these studies can limit investment, particularly when expected returns are uncertain. Competition from newer biologic drugs and targeted small molecules also presents a challenge.

Market Opportunities

Drug repurposing and formulation development represent potential opportunities. Research into additional disease applications could expand Tranilast's use if supported by clinical evidence and regulatory approvals. Formulation improvements, including extended-release versions and topical products with improved bioavailability, may also address specific treatment and compliance requirements.

View Full Report: https://www.24chemicalresearch.com/reports/292491/global-tranilast-market

Market Segmentation

The Tranilast Market is segmented by purity, application, end user, therapeutic area, and distribution channel.

By Type

Purity 98%
Purity 99%

By Application

Medication
Chemical Industry
Cosmetics & Dermatology
Research & Development

By End User

Pharmaceutical Companies
Chemical Manufacturers
Research Institutions

By Therapeutic Area

Allergy & Asthma
Dermatology (Keloids/Scars)
Other Inflammatory Conditions

By Distribution Channel

Direct Sales (B2B)
Distributors & Wholesalers
Online Pharmacies

These segments reflect Tranilast's role in pharmaceutical production, chemical supply, and research-related applications.

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/292491/global-tranilast-market

Competitive Landscape

The market features pharmaceutical and chemical suppliers serving commercial, research, and drug-development applications. Companies profiled in the report include:

Daiwa Pharmaceutical
Cayman Chemical
MANUS AKTTEVA BIOPHARMA
Enzo Life Sciences
AOBIOUS
Adooq Bioscience
FUJIFILM Wako Pure Chemical Corporation
LGM Pharma
BioChemPartner
CarboMer

Market participants supply Tranilast for pharmaceutical applications and research, with competition involving product purity, supply reliability, pricing, and specialized synthesis capabilities.